Did you know?

VBI Vaccines Inc. ( NASDAQ: VBIV) recently announced a pan-coronavirus vaccine candidate, VBI-2901, which comprises of SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins. VBI-2901 is a multivalent ...VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -14.29% and 85.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?The Insider Trading Activity of Santos Esteban on Markets Insider. Indices Commodities Currencies StocksAfter Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data ...Stocktwits is the leading social platform for investors and traders to share ideas, insights and opinions about the stock, crypto and international markets. Join the Stocktwits community, follow your favorite symbols, get real-time quotes, news, earnings and fundamentals, and buy US stocks with ease.Stay Informed on VBIV's Latest Pre Market Trades. Get the most current trading insights on VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) with Nasdaq.Find out all the key statistics for VBI Vaccines Inc. (VBIV), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.A high-level overview of VBI Vaccines Inc. (VBIV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.With SciVac trading at $0.16, the exchange rate of 20.808356 shares values the deal at roughly $3.33 per VBI share. VBI currently trades at $2.70 after a 5% jump on Friday. At the current price ...May. 15, 2024 (est.) Last Earnings Release. Apr. 16, 2024. Next Ex-Dividend Date. N/A. Last Ex-Dividend Date. N/A. In depth view into VBIV (VBI Vaccines) stock including the latest price, news, dividend history, earnings information and financials.VBI Vaccines (VBIV) will focus on its HBV vaccine product and advancing its HBV immunotherapeutic candidate. It will also reduce the workforce by 30-35% and initiate a 1-for-30 reverse stock split.VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. CAMBRIDGE, Mass., April 11, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the closing of its …Vaccine development - particularly in the Hepatitis space, appears to be a capital intensive business - Dynavax' losses in 2018, 2019 and 2020 were $159m, $153m, and $75.2m, whilst VBI's were $44m ...View VBI Vaccines Inc. (VBIV) company profile, FAQs, interesting facts, information about industry, sector and employees.VBIV is trading at a 231% premium. Price. $0.63. May 13, 2024. Fair Value. $4.61. May 13, 2024. Uncertainty. Extreme. 1-Star Price. $4.14. 5-Star Price.Find the latest dividend history for VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) at Nasdaq.com.VBIV | Complete VBI Vaccines Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.CAMBRIDGE, Mass., October 26, 2023--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the development of its next-generation mRNA-launched enveloped virus-like particle (eVLP) technology, which expands on the …A humungous storm has been raging on Jupiter for as many as 350 years, and now NASA has taken the closest-ever images of it. A humongous storm has been raging on Jupiter for at lea...VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns.Shares of VBI Vaccines (NASDAQ:VBIV) tumbled 51.7% to $1.17 on Thursday after pricing its underwritten public offering and concurrent registered direct offering to cumulatively raise $21 million ...52 Week Low Date 10/25/23. Market Cap 15.572M. Shares Out 28.43M. 10 Day Average Volume 0.23M. Dividend -. Dividend Yield -. Beta 1.90. YTD % Change -6.91.

n/a. Strong Buy. Initiates. n/a. n/a. Nov 1, 2017. A list of analyst ratings for VBI Vaccines (VBIV) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.Feb 7, 2020 · 0.6800. 54,300. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for VBIV stock on Yahoo Finance. View daily, weekly or monthly formats back to when VBI Vaccines Inc. stock was issued. Figure 8: VBIV Daily (Source: Trendspider) Looking at the daily chart, we can see the share price is stuck in the $3.00 area with a high volume of trades occurring at these prices. I expect the ...Pre-market: $0.59. (1.27%) +0.0074. Closed: May 3, 4:56:16 AM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y. MAX. search Compare to. BioCryst Pharmaceuticals Inc. $4.48. BCRX0.00%...

About VBIV. VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment ...A high-level overview of VBI Vaccines Inc. (VBIV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to Equity. Current share price of US$2.85 suggests VBI Vaccines is potentially 23% undervalued. When compared ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. VBIV earnings per share for the last quarter are 1.02 USD. Possible cause: Find the latest VBI Vaccines Inc. (VBIV) stock quote, history, news and other vital i.